TNF and neoplasm: RANK ligand (RANKL), a TNF-related molecule, has been shown to activate NF-κB in preclinical studies and thereby promote proliferative changes in the mammary epithelium as well as epithelial-mesenchymal transition, which induces tumour cell migration, invasion and metastasis [65–67].